Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

@article{Katz2016PreoperativeMF,
  title={Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.},
  author={Matthew H. G. Katz and Qian Shi and Syed Ameen Ahmad and Joseph M. Herman and Robert de Wilton Marsh and Eric A. Collisson and Lawrence H. Schwartz and Wendy L. Frankel and Robert C G Martin and William Charles Conway and Mark A Truty and Hedy Lee Kindler and Andrew M. Lowy and Tanios S. Bekaii-Saab and Philip Agop Philip and Mark S. Talamonti and D. Cardin and Noelle K. Loconte and Perry Shen and John Parker Hoffman and Alan Paul Venook},
  journal={JAMA surgery},
  year={2016},
  volume={151 8},
  pages={e161137}
}
IMPORTANCE Although consensus statements support the preoperative treatment of borderline resectable pancreatic cancer, no prospective, quality-controlled, multicenter studies of this strategy have been conducted. Existing studies are retrospective and confounded by heterogeneity in patients studied, therapeutic algorithms used, and outcomes reported. OBJECTIVE To determine the feasibility of conducting studies of multimodality therapy for borderline resectable pancreatic cancer in the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 22 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Similar Papers

Loading similar papers…